Physician profile
Catherine Tanner
NPI 1083743769
$2,417.42
in general payments reported to CMS, 2019-2025
19 companies · $782 in 2025
The $782 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $182 · 2023: $784 · 2024: $516 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $397.54 | 2022-2023 | |
| Corcept Therapeutics | $241.39 | 2025 | Korlym |
| Lilly USA, LLC | $186.32 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Viiv Healthcare Company | $148.13 | 2023-2024 | Apretude |
| Exact Sciences Corporation | $137.37 | 2023-2024 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $127.49 | 2024-2025 | Ingrezza |
| Argenx US, INC. | $125.00 | 2025 | Vyvgart |
| Mayne Pharma Commercial LLC | $125.00 | 2025 | |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $123.74 | 2024 | |
| Abbott Laboratories | $106.82 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astellas Pharma US INC | $97.54 | 2023 | Veozah |
| Eisai INC. | $91.67 | 2023 | |
| Janssen Pharmaceuticals, INC | $81.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.34 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $71.63 | 2024 | |
| Novo Nordisk INC | $67.94 | 2025 | Ozempic |
| Amneal Pharmaceuticals LLC | $48.14 | 2021-2023 | Rytary |
| Biohaven Pharmaceuticals, INC. | $37.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.